Company / Free Cash Flow per Share
ADMA Biologics, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$0.12
FY2025
5-year range
-$1.20 / $0.49
FY2021-FY2025
Trend
-75.9%
vs FY2024
Sector context
#62 of 192
Health Care
What the data says
At $0.12, ADMA Biologics, Inc.'s free cash flow per share ranks #62 of 192 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-1.93 in FY2020 to $0.49 in FY2024.
Based on SEC 10-K filings.
0.12 in FY2025.
Improved from $0.02 to $0.12 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#62 of 192 in Health CareTop 32% of 192This company $0.12 Sector average $3.32
▼
-96.5% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 75.9% year-over-year.
- Ranks #62 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.12 | -75.9% |
| FY2024 | $0.49 | +2589.8% |
| FY2023 | $0.02 | +102.8% |
| FY2022 | -$0.64 | +46.4% |
| FY2021 | -$1.20 | +38.0% |
| FY2020 | -$1.93 | -12.1% |
| FY2019 | -$1.73 | +2.1% |
| FY2018 | -$1.76 | -23.9% |
| FY2017 | -$1.42 | +16.9% |
| FY2016 | -$1.71 | +6.6% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026